Literature DB >> 18370955

Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.

E Takahashi1, N Asano, C Li, T Tanaka, K Shimada, S Shimada, T Yoshino, M Kojima, K Hara, T Eimoto, S Nakamura.   

Abstract

AIMS: To investigate the clinicopathological features of six unusual cases of nodal CD56+ and Epstein-Barr virus (EBV)+ T/natural killer (NK)-cell lymphoma, a putative nodal counterpart of nasal NK/T-cell lymphoma (nodal T/NK-cell lymphoma of nasal type) in comparison with nasal NK/T-cell lymphoma with secondary lymph node involvement (n = 24) and peripheral T-cell lymphoma (PTCL) of cytotoxic molecule (CTM)+ and EBV+ type (n = 21). METHODS AND
RESULTS: All cases of nodal T/NK-cell lymphoma of nasal type exhibited diffuse infiltration of pleomorphic medium-sized to large tumour cells, reminiscent of those in CTM+ EBV+ PTCL. The tumour cells had a typical phenotype of nasal NK/T-cell lymphoma: CD2+, CD3epsilon+, CD4-, CD5-, CD56+, T-cell intracellular antigen-1+, granzyme B+, perforin+ and EBV+. However, four of six cases demonstrated clonal T-cell receptor gamma-gene rearrangement on polymerase chain reaction analysis, unlike nasal NK/T-cell lymphoma. Comparison of clinical parameters and overall survival among the three groups demonstrated only minor differences.
CONCLUSIONS: Nodal T/NK-cell lymphoma may occupy the grey zone between extranodal nasal-type NK/T-cell lymphoma and nodal CTM+ PTCL in a spectrum of NK to T-cell lymphomas that are EBV+. The close relationship between NK/T-cell lymphomas and cytotoxic T-cell lymphomas was also substantiated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370955     DOI: 10.1111/j.1365-2559.2008.02997.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  18 in total

1.  Clinicopathologic conference: case 2.

Authors:  Shabnum Meer; Willie F P van Heerden
Journal:  Head Neck Pathol       Date:  2008-09-10

2.  Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms.

Authors:  Nodoka Sekiguchi; Naoko Asano; Toshiro Ito; Kayoko Momose; Masanobu Momose; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2012-08-14       Impact factor: 2.490

Review 3.  Natural killer cell neoplasm: biology and pathology.

Authors:  Maria Francisca Ham; Young-Hyeh Ko
Journal:  Int J Hematol       Date:  2010-12-07       Impact factor: 2.490

4.  HIV-related NK/T-cell lymphoma in the brain relapsed during intensive chemotherapy but regressed after chemotherapy discontinuation: the importance of maintaining cellular immunity.

Authors:  Yosuke Nagahata; Aiko Kato; Yukihiro Imai; Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2014-06-18       Impact factor: 2.490

5.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.

Authors:  J Han J M van Krieken
Journal:  J Hematop       Date:  2008-07       Impact factor: 0.196

6.  Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.

Authors:  Ki Sun Jung; Su-Hee Cho; Seok Jin Kim; Young Hyeh Ko; Won Seog Kim
Journal:  Int J Hematol       Date:  2016-07-25       Impact factor: 2.490

7.  Six cases of aggressive natural killer-cell leukemia in a Chinese population.

Authors:  Qiguo Zhang; Wang Jing; Jian Ouyang; Hui Zeng; Suraj K George; Zhiqiang Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 8.  Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.

Authors:  Christian Schmitt; Nouhoum Sako; Martine Bagot; Yenlin Huang; Philippe Gaulard; Armand Bensussan
Journal:  J Biomed Biotechnol       Date:  2011-04-20

Review 9.  Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.

Authors:  Margarida Lima
Journal:  Orphanet J Rare Dis       Date:  2013-07-01       Impact factor: 4.123

10.  Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.

Authors:  Nikitakis Nikolaos; Polyzois Grigorios; Katoumas Konstantinos; Titsinides Savvas; Zolota Vassiliki; Sklavounou Alexandra; Papadas Theodoros
Journal:  Am J Case Rep       Date:  2012-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.